Search

Ultra-high dose rate radiotherapy (FLASH-RT) is an external beam radiotherapy strategy that uses an extremely high dose rate (≥40 Gy/s). Compared with conventional dose rate radiotherapy (≤0.1 Gy/s), the main advantage of FLASH-RT is that it can reduce damage of organs at risk surrounding the cancer and retain the anti-tumor effect. An important feature of FLASH-RT is that an extremely high dose rate leads to an extremely short treatment time; therefore, in clinical applications, the steps of radiotherapy may need to be adjusted. In this review, we discuss the selection of indications, simulations, target delineation, selection of radiotherapy technologies, and treatment plan evaluation for FLASH-RT to provide a theoretical basis for future research. [ABSTRACT FROM AUTHOR]

Radiotherapy (RT) and radiation oncology are of essential role in the clinical treatment of cancer patients. The widely available imaging modalities such as diagnostic ultrasound, computer-assisted tomography, and contrastenhanced MRI are used in clinical practice for diagnostics and management planning. Moreover, these methods are also used to monitor the treatment upon RT. However, some diagnostic issues cannot be sufficiently resolved by the simple use of standard morphological imaging. Thus, positron emission tomography is gaining an increasing clinical relevance in the management of cancer patients undergoing RT, as it allows to visualize and quantify the tumor features at a molecular level, such as tumor metabolism or receptor expression, beyond simple morphological patterns shown by the conventional imaging. This review focuses on the recent and current advances in imaging techniques, including PET imaging, in the diagnostics and planning of RT in some cancers, namely in cervical cancer. [ABSTRACT FROM AUTHOR]

FLASH radiotherapy (FLASH-RT) is a novel radiotherapy technology defined as ultra-high dose rate (= 40 Gy/s) radiotherapy. The biological effects of FLASHRT include two aspects: first, compared with conventional dose rate radiotherapy, FLASH-RT can reduce radiation-induced damage in healthy tissue, and second, FLASH-RT can retain antitumor effectiveness. Current research shows that mechanisms of the biological effects of FLASH-RT are related to oxygen. However, due to the short time of FLASH-RT, evidences related to the mechanisms are indirect, and the exact mechanisms of the biological effects of FLASH-RT are not completely clear and some are even contradictory. This review focuses on the mechanisms of the biological effects of FLASH-RT and proposes future research directions. [ABSTRACT FROM AUTHOR]

Background: The paper covers modern approaches to the evaluation of neoplastic processes with diffusion-weighted imaging (DWI) and proposes a physical model for monitoring the primary quantitative parameters of DWI and quality assurance. Models of hindered and restricted diffusion are studied. Material and method: To simulate hindered diffusion, we used aqueous solutions of polyvinylpyrrolidone with concentrations of 0 to 70%. We created siloxane-based water-in-oil emulsions that simulate restricted diffusion in the intracellular space. To obtain a high signal on DWI in the broadest range of b values, we used silicon oil with high T2: cyclomethicone and caprylyl methicone. For quantitative assessment of our phantom, we performed DWI on 1.5T magnetic resonance scanner with various fat suppression techniques. We assessed water-in-oil emulsion as an extracorporeal source signal by simultaneously scanning a patient in whole-body DWI sequence. Results: We developed phantom with control substances for apparent diffusion coefficient (ADC) measurements ranging from normal tissue to benign and malignant lesions: from 2.29 to 0.28 mm2/s. The ADC values of polymer solutions are well relevant to the mono-exponential equation with the mean relative difference of 0.91%. Conclusion: The phantom can be used to assess the accuracy of the ADC measurements, as well as the effectiveness of fat suppression. The control substances (emulsions) can be used as a body marker for quality assurance in whole-body DWI with a wide range of b values. [ABSTRACT FROM AUTHOR]